Davis JJ - Search Results

1

JNK1-dependent antimitotic activity of thiazolidin compounds in human non-small-cell lung and colon cancer cells.

Teraishi F, Wu S, Sasaki J, Zhang L, Davis JJ, Guo W, Dong F, Fang B. Teraishi F, et al. Among authors: davis jj. Cell Mol Life Sci. 2005 Oct;62(19-20):2382-9. doi: 10.1007/s00018-005-5365-z. Cell Mol Life Sci. 2005. PMID: 16179969 Free PMC article.

2

Anticancer activity of 5-benzylidene-2-phenylimino-1, 3-thiazolidin-4-one (BPT) analogs.

Wu S, Guo W, Teraishi F, Pang J, Kaluarachchi K, Zhang L, Davis J, Dong F, Yan B, Fang B. Wu S, et al. Med Chem. 2006 Nov;2(6):597-605. doi: 10.2174/1573406410602060597. Med Chem. 2006. PMID: 17105441

3

Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells.

Zhu H, Guo W, Zhang L, Davis JJ, Teraishi F, Wu S, Cao X, Daniel J, Smythe WR, Fang B. Zhu H, et al. Among authors: davis jj. Mol Cancer Ther. 2005 Mar;4(3):451-6. doi: 10.1158/1535-7163.MCT-04-0162. Mol Cancer Ther. 2005. PMID: 15767554

4

P-glycoprotein-independent apoptosis induction by a novel synthetic compound, MMPT [5-[(4-methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone].

Teraishi F, Wu S, Sasaki J, Zhang L, Zhu HB, Davis JJ, Fang B. Teraishi F, et al. Among authors: davis jj. J Pharmacol Exp Ther. 2005 Jul;314(1):355-62. doi: 10.1124/jpet.105.085654. Epub 2005 Apr 14. J Pharmacol Exp Ther. 2005. PMID: 15831436

5

Identification of a novel synthetic thiazolidin compound capable of inducing c-Jun NH2-terminal kinase-dependent apoptosis in human colon cancer cells.

Teraishi F, Wu S, Zhang L, Guo W, Davis JJ, Dong F, Fang B. Teraishi F, et al. Among authors: davis jj. Cancer Res. 2005 Jul 15;65(14):6380-7. doi: 10.1158/0008-5472.CAN-05-0575. Cancer Res. 2005. PMID: 16024641 Free PMC article.

6

Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound.

Teraishi F, Wu S, Inoue S, Zhang L, Davis JJ, Guo W, Dong F, Fang B. Teraishi F, et al. Among authors: davis jj. Prostate. 2006 Mar 1;66(4):430-8. doi: 10.1002/pros.20373. Prostate. 2006. PMID: 16302260 Free PMC article.

7

Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells.

Teraishi F, Zhang L, Guo W, Dong F, Davis JJ, Lin A, Fang B. Teraishi F, et al. Among authors: davis jj. FEBS Lett. 2005 Dec 5;579(29):6681-7. doi: 10.1016/j.febslet.2005.10.064. Epub 2005 Nov 14. FEBS Lett. 2005. PMID: 16307741 Free PMC article.

8

Oncolytic virotherapy for cancer treatment: challenges and solutions.

Davis JJ, Fang B. Davis JJ, et al. J Gene Med. 2005 Nov;7(11):1380-9. doi: 10.1002/jgm.800. J Gene Med. 2005. PMID: 16025557 Review.

9

Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter.

Davis JJ, Wang L, Dong F, Zhang L, Guo W, Teraishi F, Xu K, Ji L, Fang B. Davis JJ, et al. Cancer Gene Ther. 2006 Jul;13(7):720-3. doi: 10.1038/sj.cgt.7700944. Epub 2006 Feb 17. Cancer Gene Ther. 2006. PMID: 16485010 Free PMC article.

10

Lack of p38 MAP kinase activation in TRAIL-resistant cells is not related to the resistance to TRAIL-mediated cell death.

Zhang L, Zhu H, Davis JJ, Jacob D, Wu S, Teraishi F, Gutierrez A, Wang Y, Fang B. Zhang L, et al. Among authors: davis jj. Cancer Biol Ther. 2004 Mar;3(3):296-301. doi: 10.4161/cbt.3.3.696. Epub 2004 Mar 16. Cancer Biol Ther. 2004. PMID: 14749540 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters